1. Dunne, Philip D, Arends, Mark J. 2024. Molecular pathological classification of colorectal cancer-an update. In Virchows Archiv : an international journal of pathology, 484, 273-285. doi:10.1007/s00428-024-03746-3. https://pubmed.ncbi.nlm.nih.gov/38319359/
2. Shen, Xin, Zhang, Shun, Guo, Zhu, Xing, Dongming, Chen, Wujun. 2020. The crosstalk of ABCA1 and ANXA1: a potential mechanism for protection against atherosclerosis. In Molecular medicine (Cambridge, Mass.), 26, 84. doi:10.1186/s10020-020-00213-y. https://pubmed.ncbi.nlm.nih.gov/32894039/
3. Zhang, Dongdong, Wang, Wenyan, Zhou, Huandi, Wang, Yu, Xue, Xiaoying. 2022. ANXA1: An Important Independent Prognostic Factor and Molecular Target in Glioma. In Frontiers in genetics, 13, 851505. doi:10.3389/fgene.2022.851505. https://pubmed.ncbi.nlm.nih.gov/35711921/
4. Wu, Liang, Liu, Changjie, Chang, Dong-Yuan, Zheng, Lemin, Chen, Min. 2021. The Attenuation of Diabetic Nephropathy by Annexin A1 via Regulation of Lipid Metabolism Through the AMPK/PPARα/CPT1b Pathway. In Diabetes, 70, 2192-2203. doi:10.2337/db21-0050. https://pubmed.ncbi.nlm.nih.gov/34103347/
5. Gibbs, Lee D, Vishwanatha, Jamboor K. 2017. Prognostic impact of AnxA1 and AnxA2 gene expression in triple-negative breast cancer. In Oncotarget, 9, 2697-2704. doi:10.18632/oncotarget.23627. https://pubmed.ncbi.nlm.nih.gov/29416802/
智鼠故事 
